Statistics about Endocrine system cancer

Prevalence and incidence statistics for Endocrine system cancer:

see also prevalence and incidence page for Endocrine system cancer

Incidence (annual) of Endocrine system cancer: 25,520 new cases for endocrine system cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)

Incidence Rate: approx 1 in 10,658 or 0.01% or 25,520 people in USA [about data]

Incidence extrapolations for USA for Endocrine system cancer: 25,520 per year, 2,126 per month, 490 per week, 69 per day, 2 per hour, 0 per minute, 0 per second.

Incidence statistics about Endocrine system cancer:

The following statistics relate to the incidence of Endocrine system cancer:

• 6,950 new male cases for endocrine system cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
• 18,570 new female cases for endocrine system cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)

Deaths from Endocrine system cancer: 2,440 estimated deaths for endocrine system cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)

Death rate extrapolations for USA for Endocrine system cancer: 2,439 per year, 203 per month, 46 per week, 6 per day, 0 per hour, 0 per minute, 0 per second.

Death statistics for Endocrine system cancer:

The following are statistics from various sources about deaths and Endocrine system cancer:

• 1,140 estimated male deaths for endocrine system cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
• 1,300 estimated female deaths for endocrine system cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)

Society statistics for Endocrine system cancer

Hospitalization statistics for Endocrine system cancer:

The following are statistics from various sources about hospitalizations and Endocrine system cancer:

• 0.72% (91,298) of hospital episodes were for malignant neoplasms of thyroid and other endocrine glands in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 86% of hospital consultations for malignant neoplasms of thyroid and other endocrine glands required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 40% of hospital episodes for malignant neoplasms of thyroid and other endocrine glands were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 60% of hospital episodes for malignant neoplasms of thyroid and other endocrine glands were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 30% of hospital admissions for malignant neoplasms of thyroid and other endocrine glands required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 10.6 days was the mean length of stay in hospitals for malignant neoplasms of thyroid and other endocrine glands in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 6 days was the median length of stay in hospitals for malignant neoplasms of thyroid and other endocrine glands in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 61 was the mean age of patients hospitalised for malignant neoplasms of thyroid and other endocrine glands in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 36% of hospitalisations for malignant neoplasms of thyroid and other endocrine glands occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 23% of hospitalisations for malignant neoplasms of thyroid and other endocrine glands occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 34% of hospitalisations for malignant neoplasms of thyroid and other endocrine glands were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 0.96% (503,982) of hospital bed days were for malignant neoplasms of thyroid and other endocrine glands in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 0.011% (1,437) of hospital consultant episodes were for neoplasm of uncertain or unknown behaviour of endocrine gland in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 88% of hospital consultant episodes for required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 48% of hospital consultant episodes for neoplasm of uncertain or unknown behaviour of endocrine gland were for neoplasm of uncertain or unknown behaviour of endocrine gland men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 52% of hospital consultant episodes for neoplasm of uncertain or unknown behaviour of endocrine gland were for neoplasm of uncertain or unknown behaviour of endocrine gland women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 20% of hospital consultant episodes for required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 10 days was the mean length of stay in hospitals for neoplasm of uncertain or unknown behaviour of endocrine gland in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 5 days was the median length of stay in hospitals for neoplasm of uncertain or unknown behaviour of endocrine gland in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 43 was the mean age of patients hospitalised for neoplasm of uncertain or unknown behaviour of endocrine gland in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 52% of hospital consultant episodes for neoplasm of uncertain or unknown behaviour of endocrine gland occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 8% of hospital consultant episodes for neoplasm of uncertain or unknown behaviour of endocrine gland occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 26% of hospital consultant episodes for neoplasm of uncertain or unknown behaviour of endocrine gland were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
• 0.017% (8,799) of hospital bed days were for neoplasm of uncertain or unknown behaviour of endocrine gland in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)

About statistics:

This page presents a variety of statistics about Endocrine system cancer. The term 'prevalence' of Endocrine system cancer usually refers to the estimated population of people who are managing Endocrine system cancer at any given time. The term 'incidence' of Endocrine system cancer refers to the annual diagnosis rate, or the number of new cases of Endocrine system cancer diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.